Timothy Mitchell
Founder at SAREUM HOLDINGS PLC
Net worth: 313 537 $ as of 2024-04-29
Profile
Timothy John Mitchell was the founder of Sareum Holdings Plc, where he held the title of Chief Executive Officer & Executive Director until his departure.
Sareum Holdings Plc was founded in 2003.
Dr. Mitchell's former positions include Director-Computational Chemistry at Cambridge Discovery Chemistry and Director-Structure Based Discovery at Millennium Pharmaceuticals Research & Development Ltd.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
SAREUM HOLDINGS PLC
0.97% | 2024-03-27 | 1,032,561 ( 0.97% ) | 313 537 $ | 2024-04-29 |
Timothy Mitchell active positions
Companies | Position | Start |
---|---|---|
SAREUM HOLDINGS PLC | Founder | 2003-07-31 |
Former positions of Timothy Mitchell
Companies | Position | End |
---|---|---|
Millennium Pharmaceuticals Research & Development Ltd. | Corporate Officer/Principal | - |
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SAREUM HOLDINGS PLC | Miscellaneous |
Private companies | 2 |
---|---|
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Commercial Services |
Millennium Pharmaceuticals Research & Development Ltd. |
- Stock Market
- Insiders
- Timothy Mitchell